Skip to Content

CloniBID Approval Status

  • FDA approved: No
  • Brand name: CloniBID
  • Generic name: clonidine hydrochloride
  • Company: Addrenex Pharmaceuticals, Inc.
  • Treatment for: High Blood Pressure

CloniBID is a 12-hour, sustained-release formulation of the centrally acting alpha-2 agonist clonidine hydrochloride under review for the treatment of hypertension.

Development Status and FDA Approval Process for CloniBID

Apr 22, 2008Sciele Pharma Announces FDA Acceptance of NDA for Addrenex Pharmaceuticals' CloniBID to Treat Hypertension
Feb 20, 2008Addrenex Pharmaceuticals Reaches Milestone with Filing of NDA for First Product, CloniBID, to Treat Hypertension

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.